Sort   by:  
 Page size 
ProteomicsProteomic characterization of CD34+ CD123+ stem cells from patients with acute myeloid leukemia
The comparative characterization of hematopoietic stem cells from healthy stem cell donors and patients with acute myeloid leukemia on a proteome level has the potential to reveal differentially regulated proteins which might be candidates for specific immunotherapy target molecules. Exemplarily, we...
ORGANISM(S): Homo sapiens (Human) 
2018-02-19 | PXD008378 | Pride
Proteomics Acute myeloid leukemia Lc-ms Aml 
UnknownA multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.
Not available
S-EPMC8179847 | biostudies-literature
UnknownYoung unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings.
Not available
S-EPMC12463653 | biostudies-literature
UnknownReal-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Not available
S-EPMC8490353 | biostudies-literature
UnknownReal-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.
Not available
S-EPMC11978746 | biostudies-literature
Sort   by:  
 Page size